Research advances in drug therapy for advanced primary liver cancer
10.3969/j.issn.1001-5256.2020.01.046
- VernacularTitle:晚期原发性肝癌的药物治疗
- Author:
Tingting PAN
1
;
Xiaonan CUI
Author Information
1. Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Liaoning, Dalian 116000, China
- Publication Type:Research Article
- Keywords:
carcinoma, hepatocellular;
drug therapy;
molecular targeted therapy;
antineoplastic combined chemotherapy protocols;
immunotherapy;
drug therapy (TCD)
- From:
Journal of Clinical Hepatology
2020;36(1):194-197
- CountryChina
- Language:Chinese
-
Abstract:
Liver cancer is one of the most common malignant tumors at present and has high incidence and mortality rates. Most patients are in the advanced stage at the time of diagnosis and thus lose the opportunity for surgery and have poor prognosis. At this time, medical treatment focusing on drug therapy becomes an important method for the treatment of advanced liver cancer, including chemotherapy, targeted therapy, immunotherapy, traditional Chinese medicine treatment, and endocrine therapy. This article reviews the recent research advances in drug therapy for advanced liver cancer.
